Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $3.45 billion. The enterprise value is $2.77 billion.
| Market Cap | 3.45B |
| Enterprise Value | 2.77B |
Important Dates
The next estimated earnings date is Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 61.98 million shares outstanding. The number of shares has increased by 8.17% in one year.
| Current Share Class | 61.98M |
| Shares Outstanding | 61.98M |
| Shares Change (YoY) | +8.17% |
| Shares Change (QoQ) | -5.18% |
| Owned by Insiders (%) | 1.11% |
| Owned by Institutions (%) | 82.51% |
| Float | 42.98M |
Valuation Ratios
The trailing PE ratio is 62.51.
| PE Ratio | 62.51 |
| Forward PE | n/a |
| PS Ratio | 16.11 |
| Forward PS | 22.69 |
| PB Ratio | 4.85 |
| P/TBV Ratio | 5.01 |
| P/FCF Ratio | 10.30 |
| P/OCF Ratio | 10.24 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 98.57, with an EV/FCF ratio of 8.25.
| EV / Earnings | 49.21 |
| EV / Sales | 13.31 |
| EV / EBITDA | 98.57 |
| EV / EBIT | 101.57 |
| EV / FCF | 8.25 |
Financial Position
The company has a current ratio of 17.26, with a Debt / Equity ratio of 0.02.
| Current Ratio | 17.26 |
| Quick Ratio | 17.13 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.37 |
| Debt / FCF | 0.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.99% and return on invested capital (ROIC) is 2.70%.
| Return on Equity (ROE) | 8.99% |
| Return on Assets (ROA) | 2.48% |
| Return on Invested Capital (ROIC) | 2.70% |
| Return on Capital Employed (ROCE) | 3.85% |
| Revenue Per Employee | $1.65M |
| Profits Per Employee | $445,976 |
| Employee Count | 126 |
| Asset Turnover | 0.30 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $894,000 in taxes.
| Income Tax | 894,000 |
| Effective Tax Rate | 1.57% |
Stock Price Statistics
The stock price has increased by +75.35% in the last 52 weeks. The beta is 2.25, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.25 |
| 52-Week Price Change | +75.35% |
| 50-Day Moving Average | 48.63 |
| 200-Day Moving Average | 44.55 |
| Relative Strength Index (RSI) | 66.11 |
| Average Volume (20 Days) | 1,043,376 |
Short Selling Information
The latest short interest is 5.91 million, so 9.54% of the outstanding shares have been sold short.
| Short Interest | 5.91M |
| Short Previous Month | 5.21M |
| Short % of Shares Out | 9.54% |
| Short % of Float | 13.76% |
| Short Ratio (days to cover) | 6.93 |
Income Statement
In the last 12 months, PTGX had revenue of $207.80 million and earned $56.19 million in profits. Earnings per share was $0.86.
| Revenue | 207.80M |
| Gross Profit | 207.80M |
| Operating Income | 27.22M |
| Pretax Income | 172.60M |
| Net Income | 56.19M |
| EBITDA | 28.05M |
| EBIT | 27.22M |
| Earnings Per Share (EPS) | $0.86 |
Balance Sheet
The company has $574.36 million in cash and $11.36 million in debt, giving a net cash position of $686.52 million or $11.08 per share.
| Cash & Cash Equivalents | 574.36M |
| Total Debt | 11.36M |
| Net Cash | 686.52M |
| Net Cash Per Share | $11.08 |
| Equity (Book Value) | 689.05M |
| Book Value Per Share | 11.13 |
| Working Capital | 570.75M |
Cash Flow
In the last 12 months, operating cash flow was $336.94 million and capital expenditures -$1.66 million, giving a free cash flow of $335.29 million.
| Operating Cash Flow | 336.94M |
| Capital Expenditures | -1.66M |
| Free Cash Flow | 335.29M |
| FCF Per Share | $5.41 |
Margins
Gross margin is 100.00%, with operating and profit margins of 13.10% and 27.04%.
| Gross Margin | 100.00% |
| Operating Margin | 13.10% |
| Pretax Margin | 27.47% |
| Profit Margin | 27.04% |
| EBITDA Margin | 13.50% |
| EBIT Margin | 13.10% |
| FCF Margin | 161.35% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.17% |
| Shareholder Yield | -8.17% |
| Earnings Yield | 1.63% |
| FCF Yield | 9.71% |
Analyst Forecast
The average price target for PTGX is $67.11, which is 20.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.11 |
| Price Target Difference | 20.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 1.67% |
| EPS Growth Forecast (5Y) | -2.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 26.67 and a Piotroski F-Score of 5.
| Altman Z-Score | 26.67 |
| Piotroski F-Score | 5 |